DRW Securities, LLC - EIGER BIOPHARMACEUTICALS INC ownership

EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 51 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
DRW Securities, LLC ownership history of EIGER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$37
-56.5%
120,3650.0%0.00%
-50.0%
Q2 2023$85
-21.3%
120,3650.0%0.00%0.0%
Q1 2023$108
-23.9%
120,3650.0%0.00%
-50.0%
Q4 2022$142
-100.0%
120,3650.0%0.00%
-78.9%
Q2 2022$758,000
-24.1%
120,3650.0%0.02%
-29.6%
Q1 2022$999,000
+59.8%
120,3650.0%0.03%
+50.0%
Q4 2021$625,000
-22.3%
120,3650.0%0.02%
-48.6%
Q3 2021$804,000
-21.6%
120,3650.0%0.04%
+9.4%
Q2 2021$1,026,000
-3.7%
120,3650.0%0.03%
-23.8%
Q1 2021$1,065,000
-28.0%
120,3650.0%0.04%
-19.2%
Q4 2020$1,479,000
+20.8%
120,365
-20.0%
0.05%
-22.4%
Q3 2020$1,224,000
+15.5%
150,365
+36.2%
0.07%
+34.0%
Q2 2020$1,060,000
+41.3%
110,3650.0%0.05%
+78.6%
Q1 2020$750,000
-54.4%
110,3650.0%0.03%
-56.2%
Q4 2019$1,644,000
+45.4%
110,3650.0%0.06%
-16.9%
Q3 2019$1,131,000
+52.4%
110,365
+57.7%
0.08%
+87.8%
Q2 2019$742,000
+195.6%
70,000
+182.8%
0.04%
+215.4%
Q4 2018$251,000
+41.8%
24,752
+67.8%
0.01%
+30.0%
Q3 2018$177,000
-24.0%
14,752
-22.8%
0.01%
-28.6%
Q2 2018$233,000
+47.5%
19,100
+19.4%
0.01%
+40.0%
Q1 2018$158,00016,0000.01%
Other shareholders
EIGER BIOPHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 694,232$8,532,0005.82%
P.A.W. CAPITAL CORP 400,000$4,916,0004.34%
Telemetry Investments, L.L.C. 128,848$1,584,0002.68%
Trellus Management Company, LLC 206,404$2,537,0002.09%
KNOTT DAVID M 295,035$3,626,0001.64%
683 Capital Management, LLC 2,683,600$32,982,0001.56%
INTERWEST VENTURE MANAGEMENT CO 764,918$9,401,0001.17%
TOWERVIEW LLC 130,000$1,598,0001.14%
Vivo Capital, LLC 1,791,257$22,015,0000.98%
Altium Capital Management LP 197,500$2,427,0000.91%
View complete list of EIGER BIOPHARMACEUTICALS INC shareholders